Almanac 2013: acute coronary syndromes

[1] Members WG, Roger VL, Go AS, et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012;125: e2-220.Search in Google Scholar

[2] Knight CJ, Timmis AD. Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology.10.5455/msm.2011.23.161-170Search in Google Scholar

Heart 2011;97:1820-7.10.1136/heartjnl-2011-300979Search in Google Scholar

[3] Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction.Search in Google Scholar

N Engl J Med 2010;362:2155-65.10.1056/NEJMoa0908610Search in Google Scholar

[4] Nolan JP, Lyon RM, Sasson C, et al. Advances in the hospital management of patients following an out of hospital cardiac arrest. Heart 2012;98:1201-6.10.1136/heartjnl-2011-301293Search in Google Scholar

[5] Fothergill RT, Watson LR, Chamberlain D, et al. Increases in survival from out-of-hospital cardiac arrest: a five year study. Resuscitation 2013;84:1089-92.10.1016/j.resuscitation.2013.03.034Search in Google Scholar

[6] Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA 2012;307:1817-26.10.1001/jama.2012.421Search in Google Scholar

[7] Stone GW, Witzenbichler B, Guagliumi G, et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet 2011;377:2193-204.10.1016/S0140-6736(11)60764-2Search in Google Scholar

[8] Kimmelstiel C, Zhang P, Kapur NK, et al. Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention. Circ Cardiovasc Interv 2011;4:171-9.10.1161/CIRCINTERVENTIONS.110.959098308614121364148Search in Google Scholar

[9] Meier P, Frohlich GM, Lansky AJ. Bleeding complications in percutaneous coronary interventions. Cardiology 2013;125:213-16.10.1159/00035158123797013Search in Google Scholar

[10] Mamas MA, Ratib K, Routledge H, et al. Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart 2012;98:303-11.10.1136/heartjnl-2011-30055822147900Search in Google Scholar

[11] Meier P, Windecker S, Lansky AJ. Radial versus femoral access for primary percutaneous coronary intervention: is there a preferred route to the heart? Heart 2012;98:269-70.10.1136/heartjnl-2011-30122522147901Search in Google Scholar

[12] Baklanov DV, Kaltenbach LA, Marso SP, et al. The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011). J Am Coll Cardiol 2013;61:420-6.10.1016/j.jacc.2012.10.032388304923265340Search in Google Scholar